Quality of life and inflammatory markers in mild asthma

Chest

Volumn 129, Issue 3, 2006, Pages 624-631

  Ehrs, Per Olof ^a   Sundblad, Britt Marie ^a   Larsson, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Airway inflammation; Bronchial responsiveness; Mild asthma; Primary care; Quality of life

Indexed keywords

BIOCHEMICAL MARKER; GLUCOCORTICOID; IMMUNOGLOBULIN E; METHACHOLINE; MOLECULAR MARKER; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERVENTILATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PEAK EXPIRATORY FLOW; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SPIROMETRY;

EID: 33645115375     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.3.624     Document Type: Article

References (28)

1. Ställberg B, Nystrom Kronander U, Olsson P, et al. Living with asthma in Sweden-the ALMA study. Respir Med 2003; 97:835-843
2. Ehrs PO, Aberg H, Larsson K. Quality of life in primary care asthma. Respir Med 2001; 95:22-30
3. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807
4. Juniper EF, Guyatt GH, Ferrie PJ, et al. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147:832-838
5. Sippel JM, Holden WE, Tilles SA, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000; 106:645-650
6. Stirling RG, Kharitonov SA, Campbell D, et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids: Asthma and Allergy Group. Thorax 1998; 53:1030-1034
7. Tsujino I, Nishimura M, Kamachi A, et al. Exhaled nitric oxide-is it really a good marker of airway inflammation in bronchial asthma? Respiration 2000; 67:64.5-651
8. Wilson N. Measurement of airway inflammation in asthma. Curr Opin Pulm Med 2002; 8:25-32
9. Lundback B. Asthma, chronic bronchitis and respiratory symptoms: prevalence and important determinants. Umeå University Medical Dissertations New Series No. 387. National Institute of Occupational Health, 1993
10. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47:81-87
11. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
12. Hedenström H, Malmberg P, Agarwal K. Reference values for lung function tests in females: regression equations with smoking variables. Bull Eur Physiopathol Respir 1985; 21:551-557
13. Hedenström H, Malmberg P, Fridriksson HV. Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci 1986; 91:299-310
14. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
15. Malmberg P, Larsson K, Thunberg S. Increased lung deposition and biological effect of methacholine by use of a drying device for bronchial provocation tests. Eur Respir J 1991; 4:890-898
16. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults; Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:53-83
17. Argyros GJ, Roach JM, Hurwitz KM, et al. Eucapnic voluntary hyperventilation as a bronchoprovocation technique: development of a standardized dosing schedule in asthmatics. Chest 1996; 109:1520-1524
18. Anderson SD, Argyros GJ, Magnussen H, et al. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 2001; 35:344-347
19. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160:2104-2117
20. Zetterquist W, Pedroletti C, Lundberg JO, et al. Salivary contribution to exhaled nitric oxide. Eur Respir J 1999; 13:327-333
21. Kharitonov SA, Gonio F, Kelly C, et al. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J 2003; 21:433-438
22. Wilson NM, James A, Uasuf C, et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001; 12:125-132
23. van Den Toorn LM, Prins JB, Overbeek SE, et al. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162:953-957
24. Boulet LP, Turcotte H, Brochu A. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest 1994; 105:1024-1031
25. Wilson NM, Bridge P, Spanevello A, et al. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000; 55:768-774
26. Turner MO, Hussack P, Sears MR; et al. Exacerbations of asthma without sputum eosinophilia. Thorax 1995; 50:1057-1061
27. Juniper EF, Wisniewski ME, Cox FM, et al. Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 2004; 23:287-291
28. Grönke L, Mucke M, Paasch K, et al. Exhaled NO as a descriptor of the quality of life status in a longitudinal analysis of patients with severe asthma [abstract]. Am J Respir Crit Care Med 2002; 165:A321